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Tecson: Federal Cosmetics Regulation

COMMENT
TOTAL MAKEOVER: FEDERAL
COSMETICS REGULATION AND ITS
NEED FOR LEGISLATIVE
OVERHAUL TO ENSURE
CONSUMER PROTECTION
JUSTICE TECSON *
“History has repeatedly shown that when there is insufficient regulatory
oversight, a few unscrupulous people or companies will exploit the vulnerable public for profit.”1
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INTRODUCTION
A woman in Florida purchased hair conditioner after viewing advertisements that promoted the product’s “safe, innovative and gentle qualities.”2 Within two weeks of using the product, she lost significant and
abnormal amounts of hair.3 Despite discontinuing usage of the product,
she continued experiencing hair loss, ultimately losing one-quarter to
one-third of the hair on her head.4 Such is the story of Amy Friedman,
one of more than 200 consumers5 harmed by WEN Cleansing Conditioner haircare products.6
Haircare products like WEN Cleansing Conditioner are categorized
as cosmetics.7 Cosmetics are defined as articles and ingredients “intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or
otherwise applied to the human body or any part thereof for cleansing,
beautifying, promoting attractiveness, or altering the appearance.”8 The
Food & Drug Administration (“FDA” or “Agency”) regulates cosmetics
marketed in the United States primarily through the Federal Food Drug
& Cosmetic Act (“FFDCA” or “Act”) of 1938.9
Over the last century, the sale and manufacturing of cosmetic products has evolved into a multibillion-dollar industry.10 In May of 2012,
the worldwide cosmetic, beauty supply, and perfume retail industry had
more than $250 billion in annual retail sales.11 In 2017, the global cosmetics market was valued at approximately $532 billion.12 Research
2

Complaint at 8, Friedman v. Guthy-Renker LLC, No 2:14-cv-06009, 2014 WL 3944013
(C.D. Cal. July 31, 2014) [hereinafter Friedman Complaint].
3
Id.
4
Id.
5
Jane E. Brody, For Cosmetics, Let the Buyer Beware, N.Y. TIMES (Aug. 7, 2017), https://
www.nytimes.com/2017/08/07/well/for-cosmetics-let-the-buyer-beware.html; see also Class Action
Lawsuits Over Wen Hair Products Gets Preliminary Settlement Approval, CBS LOS ANGELES (Oct.
31, 2016), https://losangeles.cbslocal.com/2016/10/31/class-action-lawsuit-over-wen-hair-productsgets-preliminary-settlement-approval/ (providing details of the WEN lawsuit and preliminary settlement proceedings).
6
Friedman Complaint, supra note 2, at 8-14.
7
See 21 U.S.C. § 321(i).
8
Id.
9
See 21 U.S.C. §§ 321-399 (providing the FDA with regulatory authority over food, drugs,
medical devices and cosmetics); see also FDA Authority Over Cosmetics: How Cosmetics are not
FDA-Approved, but are FDA-Regulated, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/cosmetics/cosmetics-laws-regulations/fda-authority-over-cosmetics-how-cosmetics-are-not-fda-approvedare-fda-regulated (last updated Aug. 24, 2020).
10
JAMES T. O’REILLY & KATHERINE A. VAN TASSEL, FOOD & DRUG ADMIN. § 17:1, at 1 (4th
ed. 2020).
11
AMALIA K. CORBY-EDWARDS, CONG. RESEARCH SERV., R42594, FDA REGULATION OF
COSMETICS AND PERSONAL CARE PRODUCTS 1 (2012).
12
Global Cosmetics Products Market expected to reach USD 805.61 billion by 2023 –Industry Size & Share Analysis, MARKETERS MEDIA (Mar. 13, 2018), https://marketersmedia.com/global-
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shows that the global cosmetics products market is expected to reach
approximately $805 billion by 2023.13
Although revenue within the cosmetics industry has dramatically increased in recent years, the same cannot be said of its regulation.14
Among all the FDA product categories, cosmetics products are among
the least regulated.15 Under current federal regulations, which have not
changed since 1938, the FDA has no authority to require registration and
product information from cosmetic companies, mandate pre-market testing or approval of products, or order mandatory recalls of proven or potentially hazardous products.16 Additionally, the current scheme does not
require cosmetic companies to report adverse events related to their cosmetic products to the FDA.17
In recent years, several legislative attempts to solve the lack of FDA
cosmetic regulation proved unsuccessful.18 For instance, the Safe Cosmetics and Personal Care Products Act of 2019 (“SCPCPA”) proposed
to amend the FFDCA to require cosmetic companies to register their facilities19 and provide information regarding their cosmetics’ ingredients
to the FDA.20 The SCPCPA would provide the FDA with the authority to
recall cosmetics that posed threats to consumer safety,21 ban most use of
animal testing in cosmetics,22 and fund research into safer alternatives to
hazardous ingredients that negatively affect women and girls of color.23
However, like cosmetics bills that came before it, the SCPCPA was
never passed.24
cosmetics-products-market-expected-to-reach-usd-805-61-billion-by-2023-industry-size-share-analysis/313185.
13
Id.
14
O’REILLY & VAN TASSEL, supra note 10, § 17:1, at 1 (providing a historical overview of
cosmetics regulation in the United States).
15
Some scholars believe that this is because there has not yet been an established need for
extensive federal cosmetics regulation in the United States. On the other hand, because cosmetics are
a gendered industry primarily targeted to women, some see the lack of legislative prioritization of
cosmetics law as a consequence of women’s exclusion from political participation and representation. See O’REILLY & VAN TASSEL, supra note 10, § 17:1, at 1; see also Marie Boyd, Gender, Race
& the Inadequate Regulation of Cosmetics, 30 YALE J. L. & FEMINISM 275, 307-10 (2019).
16
FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9.
17
Id.
18
See Safe Cosmetics and Personal Care Products Act of 2019, H.R. 4296, 116th Cong.
(2019).
19
Id. § 612.
20
Id. § 615.
21
Id. § 622.
22
H.R. 4296, 116th Cong. § 624; see also National Cosmetic Safety Reform, BREAST CANCER
PREVENTION PARTNERS, https://www.bcpp.org/resource/federal-cosmetic-safety-reform/ (last visited
Mar. 11, 2020).
23
H.R. 4296, 116th Cong. § 463C; see also National Cosmetic Safety Reform, supra note 22.
24
See H.R. 4296, 116th Cong. § 612.
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The cosmetic industry’s lack of federal oversight has given rise to
concerns regarding consumer safety.25 Amy Friedman’s story is one example of how the current lack of FDA cosmetic regulation causes actual
harm to consumers.26 The current regulatory scheme allows cosmetic
companies to operate with little to no government review, leaving consumers vulnerable to potential bad actors.27 This Comment discusses the
problematic effects of the current regulatory framework on the health and
safety of consumers, and explores the SCPCPA and its proposed amendments to the FDA’s regulatory authority over cosmetics. This Comment
argues that the SCPCPA is a necessary legislative solution to the current
lack of federal cosmetics regulation. Consequently, this Comment argues
that the SCPCPA should be re-introduced and passed in order to protect
the health and safety of consumers.
Part I begins with a discussion of the FFDCA and the FDA’s limited
authority to regulate cosmetics. Part II provides an overview of the proposed SCPCPA bill and its provisions. This section explores how the bill
purported to amend the FFDCA by broadening the FDA’s regulatory
power over the cosmetics industry. Part III details two instances wherein
the lack of federal oversight over cosmetics threatened consumer safety:
the WEN incident and a second one involving Johnson & Johnson talcum powder found to be contaminated with asbestos. Lastly, Part IV argues that Congress should enact the SCPCPA because it would provide
the FDA with the necessary authority to effectively regulate cosmetics
and protect consumers. This section begins by examining the provisions
of the SCPCPA in the context of the WEN and Johnson’s incidents, and
argues that these incidents could have been prevented or minimized if the
FDA had the authority the SCPCPA aimed to provide. To illustrate the
feasibility of the SCPCPA provisions, this section then looks to the success of similar provisions in California’s existing cosmetics legislature
including the state’s recently enacted Toxic-Free Cosmetics Act. Lastly,
this section addresses legislators’ concerns as to federal preemption and
the SCPCPA’s effect on small businesses.

25
See Brody, supra note 5; Tiffany Hsu & Roni Caryn Rabin, Johnson & Johnson Recalls
Baby Powder Over Asbestos Worry, N.Y. TIMES, https://www.nytimes.com/2019/10/18/business/
johnson-johnson-baby-powder-recall.html (last updated Nov. 19, 2019).
26
See Friedman Complaint, supra note 2.
27
See Priyanka Narayan, The cosmetics industry has avoided strict regulation for over a
century. Now rising health concerns has FDA inquiring, CNBC (Aug. 2, 2018, 10:08 AM), https://
www.cnbc.com/2018/08/01/fda-begins-first-inquiry-of-lightly-regulated-cosmetics-industry.html.
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I. FEDERAL COSMETICS REGULATION AND THE FDA
A. THE FEDERAL FOOD, DRUG, AND COSMETIC ACT
The federal regulation of cosmetic products began in 1938 when
Congress passed the Federal Food, Drug, and Cosmetic Act
(“FFDCA”).28 Prior to its enactment, cosmetics were regulated by a collection of state laws that were in place to regulate food and drugs.29 The
FFDCA granted the FDA the authority to regulate cosmetic products and
their ingredients.30 The FFDCA provisions that regulate the cosmetics
industry, with the exception of those pertaining to color additives, have
not changed since the Act was first passed nearly a century ago.31
The FFDCA prohibits the adulteration and misbranding of cosmetic
products in interstate commerce.32 The Act also prohibits the introduction, delivery for introduction, and receipt of such adulterated or misbranded cosmetic products into interstate commerce.33 Legislators
included these provisions in the FFDCA in reaction to several incidents
in which cosmetics allegedly caused serious problems to consumer
health.34
B. FDA REGULATORY AUTHORITY AND ITS LIMITATIONS OVER
COSMETICS
Under the FFDCA, if the FDA finds an adulterated or misbranded
cosmetic product in interstate commerce, the Agency has the power to
seize the product, seek an injunction preventing production and distribution of the product, and, in some instances, pursue criminal penalties.35 A
cosmetic company may also be sued for product liability for products

28

O’REILLY & VAN TASSEL, supra note 10, § 17:1, at 1.
CORBY-EDWARDS, supra note 11, at 5.
30
Id.
31
Some types of cosmetics are also federally regulated under the Fair Packaging and Labeling Act (FPLA) and related regulations. CORBY-EDWARDS, supra note 11, at 5.
32
21 U.S.C. § 331(b); see also 21 U.S.C. § 361(stating that a cosmetic is deemed adulterated
if it contains a poisonous substance, a substance that may otherwise injure the user under the product’s prescribed usage, or any filthy, putrid, or decomposed substance); see also 21 U.S.C. § 362
(explaining that a cosmetic is considered misbranded if its labeling is false or misleading, if its
packaging does not contain the proper labeling information or meet the listed labeling requirements,
or if the container holding the product was made, formed, or filled in a misleading manner).
33
21 U.S.C. § 331(a), (c).
34
CORBY-EDWARDS, supra note 11, at 5.
35
Id (quoting 21 U.S.C. §§ 331-334).
29
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that are adulterated, misbranded, or are otherwise in violation of the
FFDCA.36
The FDA also has the power to conduct inspections of cosmetic establishments, to ensure that the products manufactured and sold at the
facility are safe, and to evaluate the products for potential adulteration or
misbranding violations.37 The FDA may decide to inspect a facility
based on its own surveillance initiatives, the facility’s compliance history, or complaints made by a consumer.38
During these inspections, the FDA may collect samples from cosmetics establishments for examination and analysis.39 The FFDCA does
not require the FDA to notify the establishments prior to conducting inspections, only that the inspections be conducted “at reasonable times
and within reasonable limits and in a reasonable manner.”40 The FDA
does not have a required schedule for conducting inspections in cosmetic
facilities.41 The Agency acknowledges its limited inspectional authority
over cosmetics establishments as well as its lack of authority to obtain
cosmetic testing records.42
The FDA also lacks the authority to collect cosmetics information43
from companies.44 The FFDCA neither requires cosmetic facility registration nor cosmetics manufacturers to report the ingredients they use in
their products.45 Furthermore, the FFDCA does not require cosmetic establishments to report cosmetic-related injuries to the FDA.46 In contrast,
other FDA-regulated products such as food, drugs, medical devices, and
36

Id at 9-10 (citing Nicole Abramowitz, The Dangers of Chasing Youth: Regulating the Use
of Nanoparticles in Anti-Aging Products, U ILL. TECH & POLICY 199, 208-09 (Spring 2008)).
37
Id at 6.
38
Id (quoting FDA, Inspection of Cosmetics: An Overview, http://www.fda.gov/Cosmetics/
GuidanceComplianceRegulatoryInformation/ComplianceEnforcement/ucm136455.htm).
39
Id (quoting 21 U.S.C. § 374(d); FDA, Inspection of Cosmetics: An Overview, http://
www.fda.gov/Cosmetics/GuidanceComplianceRegulatoryInformation/ComplianceEnforcement/
ucm136455.htm; FFDCA § 704(c)).
40
21 U.S.C. § 374; CORBY-EDWARDS, supra note 11, at 6 (quoting 21 U.S.C. § 374(a);
FFDCA § 704(a)).
41
CORBY-EDWARDS, supra note 11, at 6.
42
O’REILLY & VAN TASSEL, supra note 10, § 17:10, at 1.
43
“Cosmetics information” includes, but is not limited to, cosmetic facility registration, cosmetic product ingredient statements, and information regarding the discontinuation or amendment of
product formulations. See Voluntary Cosmetic Registration Program, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/cosmetics/voluntary-cosmetic-registration-program (last updated Aug. 24,
2020).
44
See 21 U.S.C. § 374; O’REILLY & VAN TASSEL, supra note 10, § 17:10, at 1.
45
CORBY-EDWARDS, supra note 11, at 6 (citing 21 C.F.R. Parts 710, 720; FDA, Bad Reaction
to Cosmetics? Tell FDA, http:www.fda.gov/ForConsumers/ConsumerUpdates/ucm241820.htm).
46
Id (quoting FDA Authority Over Cosmetics, http://www.fda.gov/Cosmetics/Guidance/
ComplianceRegulatoryInformation/ucm074162.htm; Donald R. Johnson, Not in my Makeup: The
Need for Enhanced Premarket Regulatory Authority Over Cosmetics In light of Increased Usage of
Engineered Nanoparticles, 26 J. CONTEMP. HEALTH L. & POLICY 82, 114 (2009)).
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tobacco have several registration requirements.47 Drug manufacturers,
unlike cosmetics manufacturers, are required to report to the FDA adverse reactions to the drugs they produce.48
Since the FDA cannot mandate the registration of cosmetic information, whether or not a company notifies the FDA of its existence or the
formulation of its products is entirely the company’s choice.49 The
Agency created a Voluntary Cosmetic Registration Program (“VCRP”)
to be used by “manufacturers, packers, and distributors of cosmetic products that are in commercial distribution in the United States.”50 The
VCRP applies to establishments regardless of whether or not their products enter interstate commerce.51 The FDA encourages cosmetic manufacturers and packaging companies to register their establishments and
product ingredients through the VCRP within 30 days of beginning
operation.52
Furthermore, since the FDA cannot require companies to report unfavorable reactions to their cosmetic products, the Agency finds out
about adverse events in the cosmetic industry only when consumers,
manufacturers, or healthcare professionals voluntarily report them.53 Adverse events include any problems a consumer experienced when using a
cosmetic product.54 A consumer, healthcare professional, attorney, or
member of the cosmetic industry may report an adverse event related to
cosmetics by calling an FDA Consumer Complaint Coordinator, or by
completing a “Voluntary MedWatch form” on the FDA’s website.55
The FDA’s regulatory authority over the cosmetics industry is significantly less comprehensive than its authority over other FDA-regulated products such as food, biologics, and medical devices.56 For
instance, although the FDA can pursue enforcement actions against products or entities that do not comply with the law, the law does not require
47

CORBY-EDWARDS, supra note 11, at 6 (quoting 21 U.S.C. § 350d (food); 21 U.S.C. § 360
(drugs and devices); 21 U.S.C. § 387e (tobacco)).
48
Id.
49
See FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9.
50
Voluntary Cosmetic Registration Program, supra note 43.
51
21 C.F.R. § 710.1 (2019).
52
21 C.F.R. §§ 710.2, 720.4 (2019); see also CORBY-EDWARDS, supra note 11, at 22.
53
Using Adverse Event Reports to Monitor Cosmetic Safety, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/cosmetics/how-report-cosmetic-related-complaint/using-adverse-event-reportsmonitor-cosmetic-safety (last updated Nov. 3, 2017).
54
Id.
55
How to Report a Cosmetic Related Complaint, U.S. FOOD & DRUG ADMIN., https://
www.fda.gov/cosmetics/cosmetics-compliance-enforcement/how-report-cosmetic-related-complaint
(last updated Aug. 24, 2020).
56
See FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9; see also CORBY-EDWARDS, supra note 11, at 6.
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FDA approval for cosmetic products or ingredients before they go on the
market, with the exception of color additives.57 Also, the FDA does not
have the statutory authority to require pre-market notification, safety testing, or pre-market review of these cosmetic products and ingredients.58
As such, the burden falls on cosmetic establishments to ensure products
are safe before being marketed to the public.59 Cosmetics manufacturers
and companies who market cosmetics in the United States have a legal
duty to substantiate the safety of their products.60 However, neither the
law nor any FDA regulations require specific testing methods to demonstrate safety.61 The FDA promulgated that the safety of a product may be
substantiated through “(a) reliance on already available toxicological test
data on individual ingredients and on product formulations that are similar in composition to the particular cosmetic, and (b) performance of any
additional toxicological and other tests that are appropriate in light of
such existing data and information.”62
Since the FFDCA failed to specify how cosmetic products and their
ingredients should be tested, the Personal Care Products Council
(“PCPC”), the cosmetic industry’s trade association, created a Cosmetic
Ingredient Review (“CIR”) program to help provide some guidance on
the matter.63 The program reviews the safety of cosmetic product ingredients with the use of existing data, published and unpublished, of each
individual cosmetic ingredient.64 Under this program, an expert panel
analyzes the safety of cosmetic ingredients from an annual priority list.65
The list is generated based on ingredients currently used in cosmetics
commercially available in the United States, and considers information
from the VCRP as well as “toxicological considerations.”66 The panelists
then analyze the data and determine whether an ingredient is safe for use
in cosmetic products.67 However, although the CIR findings on cosmetic
ingredients are published, the cosmetic industry is under no legal obligation to act in accordance with these findings.68
57
FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9.
58
CORBY-EDWARDS, supra note 11, at 7.
59
Id at 11.
60
FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9.
61
Id.
62
FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9 (citing 40 Fed. Reg. 8763, 8916 (Mar. 3, 1975)).
63
CORBY-EDWARDS, supra note 11, at 13.
64
Id.
65
Id.
66
Id.
67
Id.
68
Id at 14.
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Additionally, under the current regulatory framework, the law does
not require cosmetics manufacturers to use Good Manufacturing Practices (“GMPs”) unless their cosmetic products are also drugs as defined
by statute.69 This is significant because, according to the FDA, adherence
to GMPs minimizes the risk of having products that violate the
FFDCA.70 And although the FDA created a Draft Guidance Document
establishing what it deems to be GMPs for cosmetics, the document lays
out non-binding recommendations rather than legally enforceable responsibilities.71 The opposite is true for the drug industry: the FDA
strictly monitors industry compliance with the current GMP regulations
that apply to drugs, as these regulations are legally enforceable and codified in the Code of Federal Regulations.72
Unlike food and medical devices, the FDA does not have the authority to order a mandatory recall of cosmetic products found to be in violation of the FFDCA.73 Rather, the FDA may request that a company recall
certain cosmetic products.74 Recalls of cosmetic products are voluntary
actions on the part of the manufacturers and distributors.75 Once a company voluntarily recalls a cosmetic product, the FDA retains the authority to monitor the progress of a recall,76 evaluate the health hazard
presented by the product,77 and ensure the public is notified when
necessary.78

69

Id at 7.
See Good Manufacturing Practice (GMP) Guidelines/Inspection Checklist for Cosmetics,
U.S. FOOD & DRUG ADMIN., https://www.fda.gov/cosmetics/cosmetics-guidance-documents/goodmanufacturing-practice-gmp-guidelinesinspection-checklist-cosmetics (last updated Aug. 24, 2020).
71
Draft Guidance for Industry: Cosmetic Good Manufacturing Practices, U.S. FOOD &
DRUG ADMIN., https://www.fda.gov/regulatory-information/search-fda-guidance-documents/draftguidance-industry-cosmetic-good-manufacturing-practices (last updated Nov. 14, 2018).
72
Current Good Manufacturing Practice (CGMP) Regulations, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/drugs/pharmaceutical-quality-resources/current-good-manufacturing-practicecgmp-regulations (last updated Sep. 21, 2020).
73
FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9; CORBY-EDWARDS, supra note 11, at 10.
74
CORBY-EDWARDS, supra note 11, at 10.
75
See FDA Authority Over Cosmetics: How Cosmetics are not FDA-Approved, but are FDARegulated, supra note 9.
76
21 C.F.R. § 7.53 (2019); FDA Recall Policy for Cosmetics, U.S. FOOD & DRUG ADMIN.,
https://www.fda.gov/cosmetics/cosmetics-recalls-alerts/fda-recall-policy-cosmetics (last updated
Aug. 24, 2020).
77
21 C.F.R. § 7.41 (2019); FDA Recall Policy for Cosmetics, supra note 76.
78
21 C.F.R. §§ 7.42(b)(2), 7.50 (2019); FDA Recall Policy for Cosmetics, supra note 76.
70
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II. THE PROPOSED SAFE COSMETICS AND PERSONAL CARE PRODUCTS
ACT OF 2019
The Safe Cosmetics and Personal Care Products Act of 2019
(“SCPCPA”) bill, introduced by Rep. Jan Schakowsky, purported to reform the regulation of cosmetics by amending the FFDCA to broaden the
FDA’s regulatory powers over cosmetics.79 The Safe Cosmetics and Personal Care Products Act of 2019 was the reintroduced version of the
2018 and 2013 bills with the same name that had died in previous
Congresses.80
If Congress had enacted the SCPCPA, the FDA would have finally
been granted some of the authority it needs to effectively regulate the
cosmetics industry. First, the SCPCPA would have required cosmetic establishments to register with the FDA.81 The FDA would then make the
list of registered establishments available to the public through publication on its website.82 The SCPCPA would have also required cosmetic
establishments to submit all safety information on their products and
product ingredients to the FDA.83 Based on the information submitted,
the FDA would then review and evaluate the safety of the cosmetic product.84 In evaluating cosmetic safety under the SCPCPA, the Agency
would be allowed to consider certain authoritative sources, such as the
Environmental Protection Agency, the International Agency for Research
on Cancer, the National Institutes of Health, the California Environmental Protection Agency, and any other government entity determined by
the FDA.85 Under the SCPCPA, cosmetic companies would also be required to report all serious adverse events to the FDA within fifteen days
after the companies receive knowledge of them.86
In addition to reporting and registration requirements, and akin to
FDA’s authority over food products, the SCPCPA would have provided
the FDA with the authority to issue mandatory recalls of products determined to be hazardous.87 Similarly, the bill would have directed the FDA
to establish a safety standard for cosmetics and issue regulations on
79

National Cosmetic Safety Reform, supra note 22.
See H.R. 4296 (116th): Safe Cosmetics and Personal Care Products Act of 2019, GOVTRACK, https://www.govtrack.us/congress/bills/116/hr4296 (last visited Jan. 12, 2021).
81
Safe Cosmetics and Personal Care Products Act of 2019, H.R. 4296, 116th Cong. § 612
(2019).
82
Id § 612(d)(1)(B).
83
Id § 615(a).
84
Id § 615(c).
85
Id § 615(c).
86
Id § 622.
87
Id § 620(d).
80
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GMPs for the industry.88 The SCPCPA bill also aimed to institute an
immediate ban on over one dozen of the most hazardous chemicals in
cosmetics89 and required full disclosure of fragrance product ingredients.90 The bill would have also banned most use of animal testing in the
development of cosmetics.91
The SCPCPA also included provisions specifically designed for the
protection of “highly exposed and vulnerable populations.”92 These vulnerable populations include infants, children, pregnant women, the elderly, salon workers, and communities of color.93 The SCPCPA is the
only federal bill to date to address the severe exposure to hazardous
chemicals experienced by salon workers and communities of color.94 The
bill would have provided for the funding of research into safer alternatives to the hazardous ingredients that negatively affect these
communities.95
III. THE FDA’S LACK OF REGULATORY AUTHORITY OVER COSMETICS
POSES A RISK TO CONSUMER SAFETY
The cosmetics industry’s heavy reliance on the self-regulation of its
establishments poses significant risks to consumer health and safety.96
Due to the FDA’s lack of statutory authority to regulate cosmetics, the
Agency is essentially powerless to protect consumers from unsafe products. Several instances illustrate this point.
In 2016, the FDA had received 1,386 adverse-event reports that
were obtained from consumers of WEN by Chaz Dean Cleansing Conditioner products (“WEN”), which marked the highest number of reports
ever received by the FDA for any haircare product.97 However, after fur88
89

Id § 614.
H.R. 4296, 116th Cong. § 616(b)(2); see also National Cosmetic Safety Reform, supra note

22.
90

H.R. 4296, 116th Cong. § 613(g).
Id § 624.
92
See National Cosmetic Safety Reform, supra note 22.
93
H.R. 4296, 116th Cong. § 611(13); see also National Cosmetic Safety Reform, supra note
91

22.
94
New Federal Bill Will Be the First in the Nation to Ensure That Beauty and Personal Care
Products Are Safe for All, BREAST CANCER PREVENTION PARTNERS (Sept. 12, 2019), https://
www.bcpp.org/resource/new-federal-bill-will-be-the-first-in-the-nation-to-ensure-that-beauty-andpersonal-care-products-are-safe-for-all/.
95
H.R. 4296, 116th Cong. § 463C; National Cosmetic Safety Reform, supra note 22.
96
See Narayan, supra note 27.
97
The FDA published a safety alert announcing that it would conduct investigations based on
the consumer reports of hair breakage, balding, rashes, and itching as a result of using WEN. Statement on FDA Investigation of WEN by Chaz Dean Cleansing Conditioners, U.S. FOOD & DRUG
ADMIN., https://www.fda.gov/cosmetics/cosmetic-products/statement-fda-investigation-wen-chazdean-cleansing-conditioners (last updated Nov. 15, 2017).
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ther investigation the Agency discovered that Chaz Dean, Inc. and
Guthy-Renker, LLC, manufacturers of WEN, received more than 21,000
complaints of hair loss and scalp damage from consumers who had used
the Cleansing Conditioner products.98 The manufacturers did not disclose information to the FDA as to what could have caused the
reactions.99
In 2016, Chaz Dean, Inc. and Guthy-Renker, LLC settled a class
action lawsuit against it filed by more than 200 consumers for $26.3
million.100 When the settlement was announced, WEN released a statement saying that its products were safe and the decision to settle was
merely a business decision meant to avoid the time-consuming and costly
process of litigation.101 As such, despite tens of thousands of complaints,
an ongoing FDA investigation, and a $26.3 million settlement of consumer claims, WEN is still allowed to sell its products and continues to
do so today.102
There has also been concern of asbestos contamination in cosmetic
products containing talc.103 In 2018, the FDA initiated an ongoing survey
of cosmetic products for asbestos contamination.104 As part of this survey, the FDA tested approximately 50 cosmetic products for the presence
of asbestos, among which were two samples of Johnson’s baby pow98

Brody, supra note 5.
FDA Information for Consumers About WEN by Chaz Dean Cleansing Conditioners, U.S.
FOOD & DRUG ADMIN., https://www.fda.gov/cosmetics/cosmetic-products/fda-information-consumers-about-wen-chaz-dean-cleansing-conditioners (last updated Nov. 3, 2017).
100
Brody, supra note 5; Class Action Lawsuits Over Wen Hair Products Gets Preliminary
Settlement Approval, CBS LOS ANGELES (Oct. 31, 2016, 11:18 PM), https://losangeles.cbslocal.com/
2016/10/31/class-action-lawsuit-over-wen-hair-products-gets-preliminary-settlement-approval/.
101
Class Action Lawsuits Over Wen Hair Products Gets Preliminary Settlement Approval,
supra note 100.
102
Julie Edgar, WEN Case Spurs Call for Beauty Product Regs, WEBMD HEALTH NEWS
(Feb. 7, 2018), https://www.webmd.com/beauty/news/20180207/wen-case-spurs-call-for-beautyproduct-regs; Brody, supra note 5.
103
Talc is a naturally occurring mineral that is used in cosmetic and personal care products to
absorb moisture, improve the feel of a product, and to prevent “caking” in makeup. Some literature
suggests a connection between the usage of talc powders and the development of ovarian cancer.
However, the research on the matter has been non-conclusive and the FDA is still conducting further
research in this area. Asbestos, on the other hand, is a known carcinogen. Since both minerals may
be found in close proximity to each other, there is the potential for contamination of talc with
asbestos. As such, it is important that manufacturers select talc mining sites carefully and take steps
to purify the talc ore sufficiently. Talc, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/cosmetics/
cosmetic-ingredients/talc (last updated Aug. 18, 2020); see also Baby powder manufacturer voluntarily recalls products for asbestos, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/news-events/
press-announcements/baby-powder-manufacturer-voluntarily-recalls-products-asbestos (last updated
Oct. 18, 2019).
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der.105 The results revealed that a sample from one lot of baby powder
contained chrysotile fibers, a type of asbestos.106
In October of 2019, Johnson & Johnson Consumer Inc. (“J&J”) voluntarily recalled the lot of baby powder that tested positive for asbestos,
which totaled around 33,000 bottles.107 Thirteen days before the FDA
released its findings, J&J CEO Alex Gorsky testified that the products
were safe.108 Despite the FDA findings, J&J stood by the safety of its
products and executed the recall only “out of an abundance of caution.”109 At the time of the announcement, there were approximately
15,000 ongoing lawsuits against J&J by plaintiffs who claimed that the
company’s talc powders had caused their cancer.110 However, this incident is the first in which J&J recalled its baby powder for asbestos contamination, and the first time the FDA announced a finding of asbestos in
the J&J product.111
In both of these cosmetic-related incidents, the public perceived a
dire lack of cosmetics regulation by the federal government.112 Consumers noted the lack of pre-market approval and testing, as well as the
FDA’s inability to order a mandatory recall of potentially injurious products.113 These concerns may have played a part in cosmetics legislation
gaining brief Congressional attention.114
IV. THE SCPCPA IS A NECESSARY AND FEASIBLE SOLUTION THAT
CONGRESS SHOULD ENACT TO PROTECT CONSUMERS
The SCPCPA’s proposal to broaden the FDA’s regulatory authority
over cosmetics is necessary to protect consumer safety. The harmful effects and safety risks resulting from the WEN and Johnson’s incidents115
105
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Id.
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Johnson & Johnson Consumer Inc. to Voluntarily Recall a Single Lot of Johnson’s Baby
Powder in the United States, U.S. FOOD & DRUG ADMIN., https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/johnson-johnson-consumer-inc-voluntarily-recall-single-lot-johnsonsbaby-powder-united-states (last updated Oct. 18, 2019); see also Johnson & Johnson confirms no
asbestos in Johnson’s Baby Powder, CNBC (Dec. 3, 2019, 7:18 PM), https://www.cnbc.com/2019/
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could have been prevented—or at the very least, minimized—if the FDA
had the statutory power that the SCPCPA aimed to provide.
First, apart from being required to register with the FDA, the cosmetics establishments would have had to submit safety information to the
Agency.116 This information would have been made readily available to
the public through the FDA website.117 From these provisions alone, the
public could have received advanced notice regarding the safety of a particular product.118 Additionally, the mandatory adverse-event reporting
proposed by the SCPCPA bill could have more swiftly alerted the FDA
to the potentially hazardous products.119 For example, in the WEN incident, if the FDA had the authority to require cosmetic establishments to
report adverse events, the Agency would have known about the adverse
effects of the cosmetic sooner.120 Under the SCPCPA, companies would
have been required to inform the FDA of any adverse events relating to
its products within fifteen days of the company’s knowledge.121 As such,
the Agency would have learned of consumer complaints regarding the
WEN products before that number reached 21,000.122
Similarly, in the Johnson’s incident, if the SCPCPA had been implemented, the FDA would have had information on the company’s talc
sources and testing methods to better substantiate the likelihood of asbestos contamination in the products.123 The FDA, through reviewing and
evaluating the safety information submitted by the respective companies,124 could have been able to identify safety concerns and notify the
public earlier, thus minimizing any consumer exposure to potentially injurious products. Additionally, had the FDA possessed the authority to
order mandatory product recalls125 in both of the instances described, the
Agency could have acted in order to lessen consumer exposure to the
potentially hazardous cosmetics. This power would have been particu116
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larly beneficial in the instance of WEN, whose harmful haircare products
are still on the market today.126
The SCPCPA’s proposal to provide the FDA with more comprehensive regulatory authority over cosmetics is also reasonable. In fact, some
of the regulatory powers proposed by the SCPCPA are already within the
Agency’s authority over other FDA-regulated products.127 For instance,
the SCPCPA would have provided the FDA with the authority to order
mandatory recalls of harmful cosmetic products—something that the
FDA already has the power to do with respect to food products.128 The
FDA can and does use its statutory power to force companies to recall
unsafe food products, effectively taking those products off the market.129
Mandatory recall authority is necessary for consumer protection, particularly in instances where a company refuses to recall products voluntarily.130 By having the power to order recalls of food products, the FDA
shields consumers from the harm that could result from companies continuing to sell unsafe food products to the public. Providing the FDA
with mandatory recall authority over cosmetics would similarly protect
consumers from harm caused by having hazardous cosmetic products on
the market.
The SCPCPA’s mandatory registration, ingredient disclosure, and
adverse-event reporting provisions would provide the FDA with the
power to collect vital information on cosmetics, allowing for swifter regulation and added protection for consumers. With this power, the FDA
would be able to find out earlier whether a product is hazardous or in
violation of the FFDCA. The Agency would no longer be limited to
whatever information, if any, a company is willing to provide as to a
product’s ingredients and safety. Neither would the Agency have to rely
solely on voluntary adverse event reports from consumers and other parties in order to know if a product has caused harm. And since information on a product’s ingredients and safety would be made available to the
public under the SCPCPA, consumers would have notice of potentially
harmful cosmetic products.131
126
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The success of mandatory ingredient disclosure and reporting provisions is best seen in California’s cosmetics legislation. In 2005, California enacted the California Safe Cosmetics Act, codified in California
Health & Safety Code, section 111791.132 This California Act was the
country’s first state cosmetics regulatory act.133 In passing the statute, the
legislature noted the lack of federal regulation and weaknesses in FDA
regulatory authority over cosmetics.134 As a way of strengthening cosmetic regulation, the California Safe Cosmetics Act requires cosmetics
establishments to report the use of potentially harmful products or ingredients to California’s Department of Health Services (“DHS”).135 Manufacturers selling cosmetic products in California must notify the DHS of
any product containing “any ingredient that is a chemical identified as
causing cancer or reproductive toxicity.”136 The DHS then notifies the
public of this information.137 Additionally, under the California Safe
Cosmetics Act, the DHS has the authority to require manufacturers to
submit health effects data, and to investigate whether products could be
toxic under a consumer’s ordinary usage.138 Manufacturers in California
that do not comply with the DHS could face legal action.139
From 2007 to 2013, California has identified five additional hazardous chemicals that manufacturers are required to disclose, under the act’s
mandatory reporting requirements.140 Within this time, in addition to
making the reporting system available online, the state notified approximately 7,000 manufacturers that they were out of compliance with the
act’s provisions.141 Furthermore, and perhaps most notably, under the act
the California Attorney General was able to obtain an injunction against
the manufacturer of “Brazilian Blowout,” a Brazilian hair relaxing treatment that was found to emit formaldehyde gas, a known carcinogen.142
132
See Meryl C. Maneker & Vickie E. Turner, Cosmetics and Beauty Product Litigation, 59
THE PRACTICAL LAW. 29, 31 (2013), http://www.wilsonturnerkosmo.com/tasks/sites/wtk/assets/Image/TPL1302_Maneker.pdf.
133
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The achievements of the California Safe Cosmetics Act indicate that
mandatory reporting and ingredient disclosure provisions are essential to
strengthening cosmetics regulations. Furthermore, the success of such
provisions on a state level help show the kind of impact similar provisions may have on a federal level. In enacting the California Safe Cosmetics Act and requiring companies to report key cosmetic information
to the DHS, California essentially expedited the regulatory process for
cosmetics by eliminating any prior hurdles the state agency faced due to
a lack of access to information. Through the act, the state is able to effectively protect its consumers by identifying hazardous chemicals in cosmetic products and promptly notifying the public. The act also enables
the state to hold companies accountable for the safety of their products.
The SCPCPA’s proposal to provide the FDA with the power to collect
cosmetics information from companies would similarly expedite the federal cosmetics regulatory process, afford additional protection for consumers, and hold companies accountable for the safety of products they
sell on the market.
Additionally, the SCPCPA’s proposal to ban certain known toxic
chemicals from cosmetics and personal care products is an attainable solution that is a necessary step in ensuring the safety of consumers. Again,
California’s state legislature best illustrates this point. As of September
2020, California became the first state to ban twenty-four toxic chemicals in cosmetics and personal care products.143 The Toxic-Free Cosmetics Act, codified in California Health & Safety Code, section 108980, is
the nation’s first state-level ban of certain toxic ingredients for use in
cosmetic products and personal care products.144 Among these banned
ingredients are formaldehyde and the most toxic types of phthalates and
parabens,145 some of which the SCPCPA proposed to ban as well.146 The
passing of such state legislation is a testament to the shortcomings of
current federal legislation, and an indication that banning toxic chemicals
from cosmetics and personal care products is necessary and feasible. A
parallel federal level proposition is a reasonable solution.
Through its provisions, the SCPCPA would have protected not only
regular consumers but vulnerable populations as well.147 The SCPCPA
143
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§ 616 (2019).
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was the only federal bill to tackle the disparate effect of the cosmetics
industry on people of color and professional salon workers.148 An analysis by the Environmental Working Group (“EWG”) showed that cosmetics marketed towards Black women were more likely to contain harmful
ingredients than those marketed towards the general public.149 The EWG
also found that in 1,177 beauty and personal care products which were
aimed towards Black women, about one in twelve was classified as
“highly hazardous,” according to the EWG’s scoring system.150 By supporting research on cosmetics-related health disparities that impact these
communities, the SCPCPA purported to lessen their exposure to toxic
chemicals.151 The bill also proposed to create a safety standard for cosmetics and to fund research into safer alternatives for toxic ingredients,152 which would have helped ensure a level of protection for these
vulnerable and highly-exposed communities.153
Republican lawmakers had expressed concerns regarding the
SCPCPA’s proposed changes to FDA regulatory authority.154 Rep.
Michael Burgess noted that the SCPCPA did not adequately address the
issue of federal preemption and harmonization between federal and state
legislature.155 According to Rep. Burgess, any law passed on this issue
should contain language stating that federal laws preempt any state
laws.156 Yet although the concerns regarding preemption are valid, having a robust preemption clause may discourage states and local governments from enacting laws stronger or more tailored to their residents than
the prevailing federal law.157 Rather than a preemption clause, the
12, 2019), https://www.bcpp.org/resource/new-federal-bill-will-be-the-first-in-the-nation-to-ensurethat-beauty-and-personal-care-products-are-safe-for-all/.
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SCPCPA contained a savings clause allowing states and local governments to establish stricter requirements than those set forth in the bill.158
Rep. Schakowsky’s office, in a section-by-section summary of the
SCPCPA, stated: “This bill acts as a floor, not a ceiling.”159
Rep. Burgess also voiced his concern on the bill’s effect on small
businesses, and noted that the bill would not exempt these businesses
from the proposed registration fees and requirements.160 However, the
SCPCPA bill did contain an exemption for businesses with annual cosmetic sales less than $1,000,000.161 Under the SCPCPA, these businesses, termed “microbusinesses,” would be exempt from the bill’s
registration fees and requirements.
The introduction of the SCPCPA reinforced the notion that the current regulatory framework for cosmetics is outdated and in need of
change. Allowing the cosmetics industry to continue to self-regulate with
almost no federal oversight leaves the public at the mercy of cosmetic
establishments and their inherently greedy business interests.162 The
FDA regulatory authority over cosmetics needs to be strengthened in order to protect consumer safety, and given the current state of federal
cosmetics regulation in the country, anything less than the legislative
makeover proposed by the SCPCPA may fall short of providing adequate
consumer protection.
CONCLUSION
The current regulatory framework for cosmetics is detrimental to
consumer safety.163 Under the current scheme, the FDA has no statutory
authority to require cosmetic companies to submit information on their
products, to require pre-market testing or approval of cosmetic products,
or to order mandatory recalls of proven or potentially hazardous products.164 As it stands, the FDA is ill-equipped to prevent consumers from
exposure to harmful cosmetics, as demonstrated by the WEN case and
the recent instance of asbestos contamination in Johnson & Johnson’s
products.165
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Congress should reintroduce and pass the SCPCPA, which would
amend the FFDCA to provide FDA with the necessary regulatory authority over cosmetics in order to effectively protect consumers.166 Under the
SCPCPA, the FDA would have the authority to order mandatory recalls,
require adverse-event reporting, and mandate the registration of cosmetics companies and reporting of their product ingredients and safety information.167 Broadening the FDA’s statutory authority through the
SCPCPA could also expedite the regulatory processes for cosmetics and
allow the Agency to identify potentially harmful products before they are
exposed to unknowing consumers.
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